Alendronic-acid/denosumab

Rebound associated multiple vertebral fractures and allergic reaction: 3 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Anastasilakis AD, et al. Rebound-associated vertebral fractures may occur in sequential time points following denosumab discontinuation: need for prompt treatment re-initiation. Bone Reports 12: Jun 2020. Available from: URL: http://doi.org/10.1016/j.bonr.2020.100267

      Article  Google Scholar 

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Alendronic-acid/denosumab. Reactions Weekly 1806, 25 (2020). https://doi.org/10.1007/s40278-020-79043-7

    Download citation